Hans Vos
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 6
- Genetics 5
- Chronic Lymphocytic Leukemia Research 3
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 2
- Co-authors
- Sibrand Poppema (7 shared papers)Lydia Visser (7 shared papers)Harry Hollema (1 shared paper)Frits R. Rosendaal (4 shared papers)Rogier M. Bertina (2 shared papers)Jeroen Eikenboom (1 shared paper)Auguste Sturk (1 shared paper)Pieter W. Kamphuisen (1 shared paper)
- Journals
- Blood (5 papers)Thrombosis and Haemostasis (4 papers)Haematologica (2 papers)PLoS ONE (2 papers)Molecular Immunology (1 paper)
- Partner nations
- NetherlandsChinaGermany
In The Last Decade
Hans Vos
17 papers receiving 946 citations
Peers
Comparison fields: 5 of 75
- Internal Medicine 115
- Pathology and Forensic Medicine 313
- Immunology 353
- Hematology 182
- Genetics 139
Countries citing papers authored by Hans Vos
This map shows the geographic impact of Hans Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Vos more than expected).
Fields of papers citing papers by Hans Vos
This network shows the impact of papers produced by Hans Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Vos. The network helps show where Hans Vos may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Vos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 212 | |
| 2 | Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. | 1987 | 210 |
| 3 | 2007 | 96 | |
| 4 | 2006 | 85 | |
| 5 | 1987 | 79 | |
| 6 | 1989 | 72 | |
| 7 | 2011 | 49 | |
| 8 | 1991 | 40 | |
| 9 | 2011 | 32 | |
| 10 | 2008 | 31 | |
| 11 | 2011 | 22 | |
| 12 | 2010 | 15 | |
| 13 | 2000 | 11 | |
| 14 | 1999 | 11 | |
| 15 | 2010 | 4 | |
| 16 | 1989 | 4 | |
| 17 | 2009 | 1 |
About Hans Vos
Hans Vos is a scholar working on Pathology and Forensic Medicine, Genetics, Hematology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 17 papers that have together received 974 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Galectins and Cancer Biology (2 papers) and Hemophilia Treatment and Research (2 papers). The work is most often cited by research in Internal Medicine (115 citations), Pathology and Forensic Medicine (313 citations), Immunology (353 citations), Hematology (182 citations) and Genetics (139 citations). Hans Vos has collaborated with scholars based in Netherlands, China and Germany. Frequent co-authors include Sibrand Poppema, Lydia Visser, Harry Hollema, Frits R. Rosendaal, Rogier M. Bertina, Jeroen Eikenboom, Auguste Sturk, Pieter W. Kamphuisen, Anke van den Berg and Arjan Diepstra. Their work appears in journals such as Blood, Thrombosis and Haemostasis, Haematologica, PLoS ONE and Molecular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.